<!DOCTYPE html><html lang="en"><head><meta charSet="utf-8"/><meta name="viewport" content="width=device-width, initial-scale=1.0, minimum-scale=1.0, maximum-scale=5.0, shrink-to-fit=no"/><link href="https://insights.covermymeds.com/css/covermystyles.css" rel="stylesheet"/><title>A Change of Pace for Accessing Specialty Medications | CoverMyMeds</title><meta name="description" content="AMP: Access for More Patients, a new technology-driven solution from CoverMyMeds and RxCrossroads by McKesson, solves for many challenges accompanying specialty meds by leveraging network connections and creating efficiencies within provider workflows. "/><meta property="og:url" content="https://insights.covermymeds.com/healthcare-industry/specialty-therapy/a-change-of-pace-for-accessing-specialty-medications"/><meta property="og:type" content="article"/><meta property="og:title" content="A Change of Pace for Accessing Specialty Medications"/><meta property="og:description" content="AMP: Access for More Patients, a new technology-driven solution from CoverMyMeds and RxCrossroads by McKesson, solves for many challenges accompanying specialty meds by leveraging network connections and creating efficiencies within provider workflows. "/><meta property="og:image" content="https://images.ctfassets.net/70w6ftfzv4je/6TlTPN2Mv81tEzj5OmZSyc/153e4bbc6ed745e218bac708cb84be32/CMM_13803_preview.jpg"/><meta name="twitter:title" content="A Change of Pace for Accessing Specialty Medications"/><meta name="twitter:description" content="AMP: Access for More Patients, a new technology-driven solution from CoverMyMeds and RxCrossroads by McKesson, solves for many challenges accompanying specialty meds by leveraging network connections and creating efficiencies within provider workflows. "/><meta name="twitter:image" content="https://images.ctfassets.net/70w6ftfzv4je/6TlTPN2Mv81tEzj5OmZSyc/153e4bbc6ed745e218bac708cb84be32/CMM_13803_preview.jpg"/><meta name="next-head-count" content="13"/><meta charSet="utf-8"/><meta http-equiv="x-ua-compatible" content="ie=edge"/><link rel="apple-touch-icon" sizes="152x152" href="https://insights.covermymeds.com/apple-touch-icon.png"/><link rel="icon" type="image/png" sizes="32x32" href="https://insights.covermymeds.com/favicon-32x32.png"/><link rel="icon" type="image/png" sizes="16x16" href="https://insights.covermymeds.com/favicon-16x16.png"/><link rel="manifest" href="https://insights.covermymeds.com/site.webmanifest"/><link rel="mask-icon" href="https://insights.covermymeds.com/safari-pinned-tab.svg" color="#5bbad5"/><meta name="msapplication-TileColor" content="#ffffff"/><meta name="theme-color" content="#ffffff"/><meta property="og:type" content="website"/><meta property="og:site_name" content="CoverMyMeds Insights"/><meta name="twitter:card" content="summary_large_image"/><meta name="twitter:site" content="@CoverMyMeds"/><meta name="twitter:creator" content="@CoverMyMeds"/><script data-nscript="beforeInteractive">window.dataLayer = window.dataLayer || [];</script><script data-nscript="beforeInteractive">(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-N7XK4K7V');</script><script data-nscript="beforeInteractive">(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-WDWQ49P');</script><noscript data-n-css=""></noscript><script defer="" nomodule="" src="https://insights.covermymeds.com/_next/static/chunks/polyfills-c67a75d1b6f99dc8.js"></script><script src="https://www.googletagmanager.com/gtag/js?id=UA-7780355-10" defer="" data-nscript="beforeInteractive"></script><script src="https://insights.covermymeds.com/_next/static/chunks/webpack-494ed913da5fcfcb.js" defer=""></script><script src="https://insights.covermymeds.com/_next/static/chunks/framework-a5db9874e40342e2.js" defer=""></script><script src="https://insights.covermymeds.com/_next/static/chunks/main-49a164b0f3a8e46a.js" defer=""></script><script src="https://insights.covermymeds.com/_next/static/chunks/pages/_app-13c75eb39ee14d5c.js" defer=""></script><script src="https://insights.covermymeds.com/_next/static/chunks/2852872c-8365a197463ecf88.js" defer=""></script><script src="https://insights.covermymeds.com/_next/static/chunks/75fc9c18-5d7ef8be35b25812.js" defer=""></script><script src="https://insights.covermymeds.com/_next/static/chunks/99-c7953fb30a1e0577.js" defer=""></script><script src="https://insights.covermymeds.com/_next/static/chunks/600-f5f4b6e59ed1df20.js" defer=""></script><script src="https://insights.covermymeds.com/_next/static/chunks/964-ce4c7614b8122314.js" defer=""></script><script src="https://insights.covermymeds.com/_next/static/chunks/pages/%5Bcategory%5D/%5Btopic%5D/%5Bslug%5D-52f9a626b18dc918.js" defer=""></script><script src="https://insights.covermymeds.com/_next/static/7yVo0_otchyu3Fx5tbzU0/_buildManifest.js" defer=""></script><script src="https://insights.covermymeds.com/_next/static/7yVo0_otchyu3Fx5tbzU0/_ssgManifest.js" defer=""></script></head><body><div id="__next"><nav class="b-caption c-nav c-nav--insights"><div class="c-nav__wrap"><div class="c-nav__logo-link u-disp-flex"><a class="b-bare" href="https://covermymeds.com/main"><img class="b-bare c-nav__logo u-disp-block" width="178" height="30" src="https://images.ctfassets.net/70w6ftfzv4je/1oZePEp9g2zGMawzERET3t/d7ec9b3ededa68f326d52fd9c8799b32/logo-industry.svg" alt="CoverMyMeds Industry Home"/></a><a class="b-bare" href="../../index.html"><img class="b-bare c-nav__logo c-nav__logo--insights u-disp-block u-mar-left-10" width="84" height="30" src="https://images.ctfassets.net/70w6ftfzv4je/49UTUWqRDaswlebMdeKNeQ/bcf919b012da6a2c325199d2bcad1a67/logo-insights.svg" alt="CoverMyMeds Insights Home"/></a></div><div class="c-nav__menu"><ul class="b-bare c-nav__group"><li class="b-bare"><a class="b-bare c-nav__action" href="https://insights.covermymeds.com/healthcare-industry">Industry<span aria-hidden="true" class="c-nav__bold-spacer" data-label="Industry"></span></a></li><li class="b-bare"><a class="b-bare c-nav__action" href="https://insights.covermymeds.com/patient-experience">Patient Experience<span aria-hidden="true" class="c-nav__bold-spacer" data-label="Patient Experience"></span></a></li><li class="b-bare"><a class="b-bare c-nav__action" href="https://insights.covermymeds.com/healthcare-technology">Healthcare Technology<span aria-hidden="true" class="c-nav__bold-spacer" data-label="Healthcare Technology"></span></a></li><li class="b-bare"><a class="b-bare c-nav__action" href="https://insights.covermymeds.com/medication-access-report">Reports<span aria-hidden="true" class="c-nav__bold-spacer" data-label="Reports"></span></a></li><li class="b-bare"><a class="b-bare c-nav__action" href="https://insights.covermymeds.com/press">Press<span aria-hidden="true" class="c-nav__bold-spacer" data-label="Press"></span></a></li><li class="b-bare"><a class="b-bare c-nav__action" href="https://experience.covermymeds.com/culture-blog">Culture<span aria-hidden="true" class="c-nav__bold-spacer" data-label="Culture"></span></a></li><li class="b-bare"><div class="c-nav__action u-mar-right-0"><a class="c-cta" href="../../subscribe/index.html"><span class="b-txt-btn c-cta__txt">Subscribe</span></a></div></li></ul></div><div class="c-nav__toggle"><button class="b-bare c-hamburger" aria-label="Toggle Navigation Menu"><span class="c-hamburger__layer"></span><span class="c-hamburger__layer"></span><span class="c-hamburger__layer"></span></button></div></div></nav><main class="itcss"><div class="o-edge "><article class="o-article-content o-article-content--full u-mar-top-80"><aside class="c-progress-bar c-progress-bar--insights c-progress-bar--hidden"><div class="o-edge u-pos-rel u-disp-flex u-align-center"><div class="c-progress-bar__logo-wrap"><a class="b-bare" href="https://www.covermymeds.com/main"><img class="b-bare c-progress-bar__logo u-disp-block" width="178" height="30" src="https://images.ctfassets.net/70w6ftfzv4je/1oZePEp9g2zGMawzERET3t/d7ec9b3ededa68f326d52fd9c8799b32/logo-industry.svg" alt="CoverMyMeds Industry Home"/></a><a class="b-bare" href="../../index.html"><img class="b-bare c-progress-bar__logo c-progress-bar__logo--insights u-disp-block u-mar-left-20" width="84" height="30" src="https://images.ctfassets.net/70w6ftfzv4je/49UTUWqRDaswlebMdeKNeQ/bcf919b012da6a2c325199d2bcad1a67/logo-insights.svg" alt="CoverMyMeds Insights Home"/></a></div><hr class="b-bare c-progress-bar__sep"/><h4 class="b-headline-4 b-headline-4--serif">A Change of Pace for Accessing Specialty Medications</h4><div class="u-mar-left-auto"><a class="c-cta" href="../../subscribe/index.html"><span class="b-txt-btn c-cta__txt">Subscribe</span><img class="c-cta__icon" src="https://images.ctfassets.net/70w6ftfzv4je/4KWzJ87hflPLKaBdDBJO9r/eac3053272e9d8dd84102dc3bf3c99b0/arrow-right.svg" alt=""/></a></div></div><progress class="c-progress-bar__indicator" min="0" value="0" max="0">Article Progress: <!-- -->NaN<!-- -->%</progress></aside><header class="o-article-content o-article-content--medium u-mar-bottom-80"><div><span class="b-txt-btn u-disp-block"><a class="b-bare o-underline-hover u-color-magenta" href="https://insights.covermymeds.com/topics/specialty-therapy">Specialty Therapy</a></span><h1 class="b-headline-2 b-headline-2--serif u-mar-top-20">A Change of Pace for Accessing Specialty Medications</h1></div><div class="o-article-content o-article-content--medium"><p class="b-body b-body--large">Among ~5.8 billion prescriptions filled each year, about 2 percent (or 116 million) are written for specialty therapies.<span class="c-inline-reference "><sup><button class="b-bare o-underline-hover u-color-magenta u-fw-bold" aria-label="Footnote 1" aria-expanded="false">[<!-- -->1<!-- -->]</button></sup><span class="b-caption u-color-black u-fw-normal c-inline-reference__content" data-footnote-number="1" start="1"><a class="b-link" target="_blank" href="https://www.iqvia.com/institute/reports/medicine-use-and-spending-in-the-us-review-of-2017-outlook-to-2022">Medicine Use and Spending in the U.S., A Review of 2017 and Outlook to 2022, IQVIA Institute, 2018</a></span></span> These medications can be highly complex and significantly more expensive than traditional pharmaceuticals — presenting patients with some of the most difficult prescription access challenges in healthcare.</p></div><div class="u-disp-flex u-justify-between u-align-center u-mar-vt-40"><div class="c-author"><div class="b-bare c-author__img-wrap"><img class="c-author__img" src="https://images.ctfassets.net/70w6ftfzv4je/6pLPtmI9DH1ZyvqCm3KilS/c6eb630b61f9c4344deebd89f6f9eb08/CMM_Leadership_12-6-75.jpg?w=120&amp;h=120&amp;fit=fill&amp;f=face&amp;fm=jpg&amp;fl=progressive" alt="Erica Conroy, PhD"/></div><div class="c-author__content"><span class="b-body b-body--serif b-body--small u-disp-block">Erica Conroy, PhD</span><span class="b-body b-body--serif b-body--small u-color-grey-4a u-fs-italic u-disp-block">VP, Specialty               </span></div></div><div class="b-body">October 10th, 2019</div></div></header><figure class="o-article-content o-article-content--full u-mar-vt-40"><img src="https://images.ctfassets.net/70w6ftfzv4je/6TlTPN2Mv81tEzj5OmZSyc/153e4bbc6ed745e218bac708cb84be32/CMM_13803_preview.jpg" class="u-disp-block u-width-100" alt="A concerned female patient listening to a provider"/><figcaption class="b-caption u-txt-right u-mar-vt-10"> </figcaption></figure><div class="o-article-content o-article-content--sidebar"><ul class="b-bare u-disp-flex u-disp-block@80"><li class="b-bare u-mar-vt-20 u-mar-right-20 u-mar-right-0@80"><a class="c-social" href="https://www.linkedin.com/shareArticle?url=https://insights.covermymeds.com/healthcare-industry/specialty-therapy/a-change-of-pace-for-accessing-specialty-medications&amp;title=A Change of Pace for Accessing Specialty Medications" target="blank"><img class="c-social__button" src="https://images.ctfassets.net/70w6ftfzv4je/3l05PCFsfkuO0E69ODrskz/9a3374c46d1533075d68587179f92256/LinkedinSVG.svg" alt="LinkedIn"/></a></li><li class="b-bare u-mar-vt-20 u-mar-right-20 u-mar-right-0@80"><a class="c-social" href="https://twitter.com/share?url=https://insights.covermymeds.com/healthcare-industry/specialty-therapy/a-change-of-pace-for-accessing-specialty-medications&amp;text=A Change of Pace for Accessing Specialty Medications" target="blank"><img class="c-social__button" src="https://images.ctfassets.net/2in405srp47m/5qC5FTWs5i9hldrP3Gw4RY/4ac7928183101e32fc36d2857ac65b3f/xSvg.svg" alt="Twitter"/></a></li><li class="b-bare u-mar-vt-20 u-mar-right-20 u-mar-right-0@80"><a class="c-social" href="https://www.facebook.com/sharer/sharer.php?u=https://insights.covermymeds.com/healthcare-industry/specialty-therapy/a-change-of-pace-for-accessing-specialty-medications" target="blank"><img class="c-social__button" src="https://images.ctfassets.net/70w6ftfzv4je/4TWTVGhErTrzu6Pqa86Iu/3db9ce4c262a9d317b7b5a377e913615/social_fb.svg" alt="Facebook"/></a></li><li class="b-bare u-mar-vt-20"><button class="b-bare c-social"><img class="c-social__button" src="https://images.ctfassets.net/70w6ftfzv4je/5C1XXVO5g27moEkfCWLWCW/ffd9fc8936f9adabbc197186d3e30c9d/copyLink_icon.svg" alt="Copy Button"/></button></li></ul></div><div><div class="o-article-content o-article-content--drop-cap"><p class="b-body u-mar-vt-25">Compared to conventional medications, patients and providers must complete additional clinical and administrative requirements before specialty medications can be dispensed or reimbursed. Complicated workflows, along with back and forth transactions among healthcare stakeholders, can leave patients struggling to get the therapies they need. <a class="u-color-magenta" href="https://www.covermymeds.com/main/solutions/life-sciences/specialty/" title="AMP: Access for More Patients" target="blank">AMP: Access for More Patients™</a>, a new technology-driven solution from CoverMyMeds and RxCrossroads by McKesson, solves for many challenges accompanying specialty medications by leveraging network connections and creating efficiencies within provider workflows.</p>
<p class="b-body u-mar-vt-25">AMP changes the way providers and patients experience support services for specialty medications. At each stage of the specialty workflow, AMP creates efficiencies and applies network solutions to overcome long-standing challenges.</p>
<h2 class="b-headline-4 u-mar-top-75 u-pad-bottom-10">Support Challenges</h2>
<p class="b-body u-mar-vt-25">Support programs serve as an important resource for patients beginning a specialty therapy by providing services to help with medication access, affordability and adherence. Enrolled patients are connected with financial assistance programs, receive education on their therapies and obtain the help needed to coordinate care.<span class="c-inline-reference "><sup><button class="b-bare o-underline-hover u-color-magenta u-fw-bold" aria-label="Footnote 2" aria-expanded="false">[<!-- -->2<!-- -->]</button></sup><span class="b-caption u-color-black u-fw-normal c-inline-reference__content" data-footnote-number="2" start="2"><a class="b-link" target="_blank" href="https://www.accenture.com/_acnmedia/accenture/next-gen/patient-services-survey/accenture-mc814-patient-servicesls-research-note2015-v7.pdf">Patient Services – Pharma’s Best Kept Secret, Accenture Life Sciences, 2016</a></span></span> While support services lend a much needed helping hand, a survey to 10,000 patients across several therapeutic areas found that only one in five were aware of such programs.<span class="c-inline-reference "><sup><button class="b-bare o-underline-hover u-color-magenta u-fw-bold" aria-label="Footnote 2" aria-expanded="false">[<!-- -->2<!-- -->]</button></sup><span class="b-caption u-color-black u-fw-normal c-inline-reference__content" data-footnote-number="2" start="2"><a class="b-link" target="_blank" href="https://www.accenture.com/_acnmedia/accenture/next-gen/patient-services-survey/accenture-mc814-patient-servicesls-research-note2015-v7.pdf">Patient Services – Pharma’s Best Kept Secret, Accenture Life Sciences, 2016</a></span></span> For many patients, this means their only chance of connecting with a support program is through their provider.</p>
<p class="b-body u-mar-vt-25">To enroll patients in support services, providers must be aware that a program exists for a given specialty medication and locate the correct enrollment form. After completing the form, providers have traditionally faxed it to the appropriate organization for processing (<em>i.e.</em>, pharmaceutical manufacturer, specialty pharmacy or hub provider).<span class="c-inline-reference "><sup><button class="b-bare o-underline-hover u-color-magenta u-fw-bold" aria-label="Footnote 3" aria-expanded="false">[<!-- -->3<!-- -->]</button></sup><span class="b-caption u-color-black u-fw-normal c-inline-reference__content" data-footnote-number="3" start="3"><a class="b-link" target="_blank" href="https://www.pocp.com/hit-perspecitves-automating-enrollment-specialty-prescriptions/">HIT Perspectives: Automating Enrollment for Specialty Prescriptions, Point of Partners, 2017</a></span></span> Alternatively, enrollment via web portals is sometimes available, but it’s up to providers to remember individual login credentials for each program, which can be difficult information to keep track of.<span class="c-inline-reference "><sup><button class="b-bare o-underline-hover u-color-magenta u-fw-bold" aria-label="Footnote 4" aria-expanded="false">[<!-- -->4<!-- -->]</button></sup><span class="b-caption u-color-black u-fw-normal c-inline-reference__content" data-footnote-number="4" start="4"><a class="b-link" target="_blank" href="https://www.pmlive.com/pharma_intelligence/simplifying_hcp_access_to_digital_information_1216451">Simplifying HCP Access to Digital Information, PMLiVE, 2018</a></span></span> It’s estimated that less than 10 percent of patient enrollment for specialty support services is completed electronically.<span class="c-inline-reference "><sup><button class="b-bare o-underline-hover u-color-magenta u-fw-bold" aria-label="Footnote 5" aria-expanded="false">[<!-- -->5<!-- -->]</button></sup><span class="b-caption u-color-black u-fw-normal c-inline-reference__content" data-footnote-number="5" start="5"><a class="b-link" target="_blank" href="https://pocp.com/wp-content/uploads/PDF/6-%20NCPDP_2015_ED_Summit_SpecialtyRx.pdf">Automating Specialty Pharmacy: Identifying Gaps, NCPDP, 2015</a></span></span></p>
<h2 class="b-headline-4 u-mar-top-75 u-pad-bottom-10">Specialty Prescribing and Enrollment</h2>
<p class="b-body u-mar-vt-25">AMP is revolutionizing patient access to support services for specialty medications by linking together two major steps in the specialty workflow: prescribing and enrollment. Technology innovation and key network connections allow AMP to funnel enrollment through the point of prescribing to give all patients the opportunity to experience support services. Through AMP, specialty medications can be e-prescribed to a non-dispensing pharmacy, such as ScriptHero Pharmacy, which can serve as the central location for all specialty prescriptions. Behind the scenes, AMP fulfills all the complex requirements [<em>e.g.</em>, benefits investigation (BI), benefits verification (BV), prior authorization (PA), lab scheduling, prescription titration, etc.] for starting patients on therapy, while the non-dispensing pharmacy triages prescriptions to the appropriate specialty pharmacy in a given limited distribution network for dispense to patients.</p>
<p class="b-body u-mar-vt-25">Industry-wide, the standard for specialty prescribing and enrollment has involved paper, phone and fax-based processes. Not only are phone calls and faxes outdated methods of communication – contributing to office inefficiencies for providers and their staff – there is little direction for where specialty prescriptions must be sent. As a result, more than 40 percent of faxed specialty prescriptions require call back to the provider.<span class="c-inline-reference "><sup><button class="b-bare o-underline-hover u-color-magenta u-fw-bold" aria-label="Footnote 5" aria-expanded="false">[<!-- -->5<!-- -->]</button></sup><span class="b-caption u-color-black u-fw-normal c-inline-reference__content" data-footnote-number="5" start="5"><a class="b-link" target="_blank" href="https://pocp.com/wp-content/uploads/PDF/6-%20NCPDP_2015_ED_Summit_SpecialtyRx.pdf">Automating Specialty Pharmacy: Identifying Gaps, NCPDP, 2015</a></span></span> In addition, more than 85 percent of surveyed providers reported a lack of digital access to specialty pharmacy information within their EHR systems for where to send prescriptions.<span class="c-inline-reference "><sup><button class="b-bare o-underline-hover u-color-magenta u-fw-bold" aria-label="Footnote 6" aria-expanded="false">[<!-- -->6<!-- -->]</button></sup><span class="b-caption u-color-black u-fw-normal c-inline-reference__content" data-footnote-number="6" start="6"><a class="b-link" target="_blank" href="https://www.pocp.com/wp-content/uploads/NCPDP-AC2019-Specialty-Prescribers-Tell-All-w-ACPE-slides_FINAL_SM.pdf">Specialty Prescribers Tell All, NCPDP Conference Presentation, 2019</a></span></span> AMP overcomes this challenge as providers only need to prescribe to a central, non-dispensing pharmacy, like ScriptHero Pharmacy, for specialty prescriptions to be processed and sent to the right location for dispense.</p>
<p class="b-body u-mar-vt-25">To meet providers where they are, AMP allows for enrollment into support services to be completed in multiple other ways as well. As soon as an e-prescription for a specialty medication is written, enrollment can be automatically triggered within the familiar CoverMyMeds web portal, which is already used by over 700,000 providers for submitting PA requests electronically.<span class="c-inline-reference "><sup><button class="b-bare o-underline-hover u-color-magenta u-fw-bold" aria-label="Footnote 7" aria-expanded="false">[<!-- -->7<!-- -->]</button></sup><span class="b-caption u-color-black u-fw-normal c-inline-reference__content" data-footnote-number="7" start="7"><a class="b-link" target="_blank" href="https://www.drugchannels.net/2019/05/a-new-starting-point-for-patient.html">A New Starting Point for Patient Support: Technology-Driven Hub Services, Drug Channels, 2019</a></span></span> In fact, data from <a class="u-color-magenta" href="../amp-access-for-more-patients-tm-improves-time-to-therapy-for-specialty/index.html" title="End-To-End Electronic Support Improves Patient Access for Specialty Medications" target="blank">a recent two-month pilot study</a> of a neurology medication for a narrow patient population demonstrates AMP’s advantage for reaching providers. During the pilot, 89 percent of prospective providers (<em>i.e.</em>, 501 out of 562 national provider identifiers) enrolled patients into AMP, and 48 percent of enrollments were completed electronically, as compared to the industry standard of less than 10 percent.<span class="c-inline-reference "><sup><button class="b-bare o-underline-hover u-color-magenta u-fw-bold" aria-label="Footnote 8" aria-expanded="false">[<!-- -->8<!-- -->]</button></sup><span class="b-caption u-color-black u-fw-normal c-inline-reference__content" data-footnote-number="8" start="8"><a class="b-link" target="_blank" href="../amp-access-for-more-patients-tm-improves-time-to-therapy-for-specialty/index.html">Access for More Patients Delivers End-to-End Electronic Support for Specialty Medications, CoverMyMeds, 2019</a></span></span> Data also showed that when enrollment forms were started, 92 percent were completed relative to the industry standard completion rate of 50 percent.<span class="c-inline-reference "><sup><button class="b-bare o-underline-hover u-color-magenta u-fw-bold" aria-label="Footnote 8" aria-expanded="false">[<!-- -->8<!-- -->]</button></sup><span class="b-caption u-color-black u-fw-normal c-inline-reference__content" data-footnote-number="8" start="8"><a class="b-link" target="_blank" href="../amp-access-for-more-patients-tm-improves-time-to-therapy-for-specialty/index.html">Access for More Patients Delivers End-to-End Electronic Support for Specialty Medications, CoverMyMeds, 2019</a></span></span></p>
<p class="b-body u-mar-vt-25">As an added benefit, patient information from an e-prescription is auto-populated directly into the enrollment form, helping providers to save time. If the medication is not e-prescribed, providers can also choose to manually start enrollment within the CoverMyMeds portal or use more traditional methods, like fax, to complete enrollment.</p>
<h2 class="b-headline-4 u-mar-top-75 u-pad-bottom-10">Coordinating Care</h2>
<p class="b-body u-mar-vt-25">For many patients, the reimbursement component of starting specialty therapy is most challenging. Knowing who to contact for answers and assistance can be difficult even for healthcare experts, let alone struggling patients. In fact, some patients have described working through these activities on their own as a full-time job.<span class="c-inline-reference "><sup><button class="b-bare o-underline-hover u-color-magenta u-fw-bold" aria-label="Footnote 8" aria-expanded="false">[<!-- -->8<!-- -->]</button></sup><span class="b-caption u-color-black u-fw-normal c-inline-reference__content" data-footnote-number="8" start="8"><a class="b-link" target="_blank" href="../amp-access-for-more-patients-tm-improves-time-to-therapy-for-specialty/index.html">Access for More Patients Delivers End-to-End Electronic Support for Specialty Medications, CoverMyMeds, 2019</a></span></span> Reimbursement involves processes like BI, BV and PA which require information transfer among patients, providers, pharmacies and payers. When multiple healthcare stakeholders are needed to coordinate reimbursement activities, it typically takes more time to facilitate patient care.</p>
<p class="b-body u-mar-vt-25">AMP is changing the way care is coordinated with an online self-service dashboard that facilitates workflow organization and efficiency. Stakeholders are alerted to outstanding steps along with who is responsible for completion. Through such network connectivity, AMP can increase workflow visibility and transparency among members of the patient care team while allowing for real-time transfer of pertinent information to help prevent delays in time-to-therapy.</p>
<p class="b-body u-mar-vt-25">Complicated insurance-related requirements are available for electronic fulfillment through AMP and fit within a standardized workflow to help improve efficiency and decrease time-to-therapy. In the past, these steps required weeks to fulfill – delaying time-to-therapy by eight weeks in some cases. In the <a class="u-color-magenta" href="../amp-access-for-more-patients-tm-improves-time-to-therapy-for-specialty/index.html" title="End-To-End Electronic Support Improves Patient Access for Specialty Medications" target="blank">recent AMP pilot study</a>, all three of these major reimbursement activities were completed in a total of 11 days on average.<span class="c-inline-reference "><sup><button class="b-bare o-underline-hover u-color-magenta u-fw-bold" aria-label="Footnote 8" aria-expanded="false">[<!-- -->8<!-- -->]</button></sup><span class="b-caption u-color-black u-fw-normal c-inline-reference__content" data-footnote-number="8" start="8"><a class="b-link" target="_blank" href="../amp-access-for-more-patients-tm-improves-time-to-therapy-for-specialty/index.html">Access for More Patients Delivers End-to-End Electronic Support for Specialty Medications, CoverMyMeds, 2019</a></span></span></p>
<h2 class="b-headline-4 u-mar-top-75 u-pad-bottom-10">Exception Management and Outcomes</h2>
<p class="b-body u-mar-vt-25">As specialty medications exist on a spectrum of complexity, every patient case may not be amendable to the standard workflow. These exceptions are managed by a highly skilled team of case managers that work quickly to resolve outstanding issues. After therapy begins, AMP case managers continue supporting positive outcomes through regular check-ins and communication with patients to help them remain on therapy.</p>
<p class="b-body u-mar-vt-25">Specialty medications are bringing hope to many patients suffering from difficult-to-treat conditions and rare diseases, but access barriers can stand in the way of wellness. AMP addresses the challenges confronting patients at each stage of their journeys, from access to adherence.</p>
<p class="b-body u-mar-vt-25"><strong><em>To learn more about how AMP is providing patients with the end-to-end support needed for specialty therapies, visit <a class="u-color-magenta" href="https://www.covermymeds.com/main/solutions/life-sciences/specialty/" title="AMP: Access for More Patients" target="blank">go.covermymeds.com/specialty</a>.</em></strong></p></div></div><div class="o-article-content u-mar-vt-80"><div class="c-author c-author--large"><div class="b-bare c-author__img-wrap"><img class="c-author__img" src="https://images.ctfassets.net/70w6ftfzv4je/6pLPtmI9DH1ZyvqCm3KilS/c6eb630b61f9c4344deebd89f6f9eb08/CMM_Leadership_12-6-75.jpg?w=240&amp;h=240&amp;fit=fill&amp;f=face&amp;fm=jpg&amp;fl=progressive" alt="Erica Conroy, PhD"/></div><div class="c-author__content"><span class="b-body b-body--serif u-disp-block">Erica Conroy, PhD</span><span class="b-body b-body--serif u-color-grey-4a u-fs-italic u-disp-block">VP, Specialty               </span><p class="b-body u-fw-light u-mar-top-10 u-mar-bottom-0">Erica delivered specialty solutions for patients, providers, pharmacists, payers and life sciences.</p></div></div></div><div class="o-article-content"><div class="b-caption o-expandable-source-list"><button class="b-bare u-pad-vt-20 o-expandable-source-list__btn u-disp-flex u-width-100"><div>Expand Sources</div><img class="o-expandable-source-list__arrow" src="https://images.ctfassets.net/70w6ftfzv4je/3ZNfQtyqPZ95m0ZFRrOvB5/82c57d121fa016c7c5d461cc42f51bb5/accordion-arrow.svg" alt=""/></button><ol class="b-bare o-expandable-source-list__list"><li class="b-bare u-mar-vt-10"><span>1<!-- -->.</span> <a href="https://www.iqvia.com/institute/reports/medicine-use-and-spending-in-the-us-review-of-2017-outlook-to-2022" class="u-color-magenta" target="_blank">Medicine Use and Spending in the U.S., A Review of 2017 and Outlook to 2022, IQVIA Institute, 2018</a></li><li class="b-bare u-mar-vt-10"><span>2<!-- -->.</span> <a href="https://www.accenture.com/_acnmedia/accenture/next-gen/patient-services-survey/accenture-mc814-patient-servicesls-research-note2015-v7.pdf" class="u-color-magenta" target="_blank">Patient Services – Pharma’s Best Kept Secret, Accenture Life Sciences, 2016</a></li><li class="b-bare u-mar-vt-10"><span>3<!-- -->.</span> <a href="https://www.pocp.com/hit-perspecitves-automating-enrollment-specialty-prescriptions/" class="u-color-magenta" target="_blank">HIT Perspectives: Automating Enrollment for Specialty Prescriptions, Point of Partners, 2017</a></li><li class="b-bare u-mar-vt-10"><span>4<!-- -->.</span> <a href="https://www.pmlive.com/pharma_intelligence/simplifying_hcp_access_to_digital_information_1216451" class="u-color-magenta" target="_blank">Simplifying HCP Access to Digital Information, PMLiVE, 2018</a></li><li class="b-bare u-mar-vt-10"><span>5<!-- -->.</span> <a href="https://pocp.com/wp-content/uploads/PDF/6-%20NCPDP_2015_ED_Summit_SpecialtyRx.pdf" class="u-color-magenta" target="_blank">Automating Specialty Pharmacy: Identifying Gaps, NCPDP, 2015</a></li><li class="b-bare u-mar-vt-10"><span>6<!-- -->.</span> <a href="https://www.pocp.com/wp-content/uploads/NCPDP-AC2019-Specialty-Prescribers-Tell-All-w-ACPE-slides_FINAL_SM.pdf" class="u-color-magenta" target="_blank">Specialty Prescribers Tell All, NCPDP Conference Presentation, 2019</a></li><li class="b-bare u-mar-vt-10"><span>7<!-- -->.</span> <a href="https://www.drugchannels.net/2019/05/a-new-starting-point-for-patient.html" class="u-color-magenta" target="_blank">A New Starting Point for Patient Support: Technology-Driven Hub Services, Drug Channels, 2019</a></li><li class="b-bare u-mar-vt-10"><span>8<!-- -->.</span> <a href="../amp-access-for-more-patients-tm-improves-time-to-therapy-for-specialty/index.html" class="u-color-magenta" target="_blank">Access for More Patients Delivers End-to-End Electronic Support for Specialty Medications, CoverMyMeds, 2019</a></li></ol></div></div><div class="o-article-content o-article-content--large u-mar-vt-40"><div class="c-insights-subscribe"><div class="c-insights-subscribe__content"><h4 class="b-headline-4 u-mar-right-40@40 u-mar-bottom-20">The latest healthcare insights, floated right to your inbox.</h4><div class=""><form class="c-insights-subscribe__form"><div class="c-insights-subscribe__email"><div class="b-body c-textbox c-textbox--has-background"><label for="3JH905GyvaPGd8pexLVRb2_5ENpdH3KytP2UFVaKLUvSm_field" class=" c-textbox__label">Email address</label><input class="b-bare c-textbox__field" type="email" id="3JH905GyvaPGd8pexLVRb2_5ENpdH3KytP2UFVaKLUvSm_field" pattern="[a-zA-Z0-9._%+-]+@[a-zA-Z0-9.-]+.[a-zA-Z]{2,4}$" name="email" required="" value=""/></div></div><div class="c-insights-subscribe__submit"><button class="c-btn u-width-100 undefined"><span class="c-btn__txt">Subscribe</span></button></div></form></div><div class="b-body u-disp-none gtm-subscribe-success">Thanks for your submission!</div><div class="b-body u-disp-none">There was an error submitting the form. Please refresh or try again later.</div></div><img class="c-insights-subscribe__phone" src="https://images.ctfassets.net/70w6ftfzv4je/ACelG83zRvus3FJWZr2CR/2c48a3e4fb653a9cfe05aafc0a2f1d3f/subscribe-phone.png" alt="iPhone showcasing News and Insights Article"/></div></div><aside class="u-mar-vt-80"><div class="u-disp-flex u-mar-bottom-80"><h2 class="b-headline-4 u-mar-right-auto">More From <!-- -->Industry</h2><a class="b-cta" href="https://insights.covermymeds.com/healthcare-industry">View All</a></div><div class="o-story-grid o-story-grid--three-across"><div class="o-story-grid__cell"><article class="c-story c-story--stacked"><a href="https://insights.covermymeds.com/healthcare-industry/specialty-therapy/asembia-2023-payers-pharma-and-pharmacy-discuss-patient-access" target="_self" class="b-bare c-story__img-wrap"><img class="c-story__img" src="https://images.ctfassets.net/70w6ftfzv4je/6GM3sRxEi9JsFyn7D5XbaU/bb5bc1475f4aec0e400fc5b99a9a74cd/CMM_461226_Content_Assembia_Pre_Show_Digital_v01a_Email_Header_WED_1200x600_copy_3.png?w=744&amp;h=444&amp;fit=fill&amp;f=face&amp;fm=jpg&amp;fl=progressive" alt="Asembia 2023: Payers, Pharma and Pharmacy Discuss Patient Access"/></a><div class="c-story__text"><div class="b-bare"><a class="c-cta" href="https://insights.covermymeds.com/topics/specialty-therapy"><span class="b-txt-btn c-cta__txt">Specialty Therapy</span></a><a class="b-bare c-story__title" target="_self" href="https://insights.covermymeds.com/healthcare-industry/specialty-therapy/asembia-2023-payers-pharma-and-pharmacy-discuss-patient-access"><h3 class="b-headline-4 b-headline-4--serif u-disp-block u-mar-vt-20">Asembia 2023: Payers, Pharma and Pharmacy Discuss Patient Access</h3></a></div><span class="b-body b-body--small b-body--serif u-color-grey-4a u-fs-italic">By<!-- --> <span class="b-bare c-story__author">Editorial Team </span></span></div></article></div><div class="o-story-grid__cell"><article class="c-story c-story--stacked"><a href="https://insights.covermymeds.com/healthcare-industry/specialty-therapy/asembia-2023-expectations-and-policy-impacts-for-specialty-therapies" target="_self" class="b-bare c-story__img-wrap"><img class="c-story__img" src="https://images.ctfassets.net/70w6ftfzv4je/sS7zsfkrx5lnLNNhCzIdK/f0fcb51cf003ccdc53b8ee096eee542c/CMM_461226_Content_Assembia_Pre_Show_Digital_v01a_Email_Header_MON_1200x600_copy.png?w=744&amp;h=444&amp;fit=fill&amp;f=face&amp;fm=jpg&amp;fl=progressive" alt="Asembia 2023: Expectations and Policy Impacts for Specialty Therapies"/></a><div class="c-story__text"><div class="b-bare"><a class="c-cta" href="https://insights.covermymeds.com/topics/specialty-therapy"><span class="b-txt-btn c-cta__txt">Specialty Therapy</span></a><a class="b-bare c-story__title" target="_self" href="https://insights.covermymeds.com/healthcare-industry/specialty-therapy/asembia-2023-expectations-and-policy-impacts-for-specialty-therapies"><h3 class="b-headline-4 b-headline-4--serif u-disp-block u-mar-vt-20">Asembia 2023: Expectations and Policy Impacts for Specialty Therapies</h3></a></div><span class="b-body b-body--small b-body--serif u-color-grey-4a u-fs-italic">By<!-- --> <span class="b-bare c-story__author">Editorial Team </span></span></div></article></div><div class="o-story-grid__cell"><article class="c-story c-story--stacked"><a href="https://insights.covermymeds.com/healthcare-industry/specialty-therapy/asembia-2023-an-active-and-complex-future-for-specialty-therapies" target="_self" class="b-bare c-story__img-wrap"><img class="c-story__img" src="https://images.ctfassets.net/70w6ftfzv4je/6gFLRtVmLi70w1KbolgCWo/152628a67a3649e39b2a6d7815fa4cc8/CMM_461226_Content_Assembia_Pre_Show_Digital_v01a_Email_Header_TUE_1200x600_copy_2.png?w=744&amp;h=444&amp;fit=fill&amp;f=face&amp;fm=jpg&amp;fl=progressive" alt="Asembia 2023: An Active and Complex Future for Specialty Therapies"/></a><div class="c-story__text"><div class="b-bare"><a class="c-cta" href="https://insights.covermymeds.com/topics/specialty-therapy"><span class="b-txt-btn c-cta__txt">Specialty Therapy</span></a><a class="b-bare c-story__title" target="_self" href="https://insights.covermymeds.com/healthcare-industry/specialty-therapy/asembia-2023-an-active-and-complex-future-for-specialty-therapies"><h3 class="b-headline-4 b-headline-4--serif u-disp-block u-mar-vt-20">Asembia 2023: An Active and Complex Future for Specialty Therapies</h3></a></div><span class="b-body b-body--small b-body--serif u-color-grey-4a u-fs-italic">By<!-- --> <span class="b-bare c-story__author">Editorial Team </span></span></div></article></div></div></aside></article></div></main><footer class="b-body c-footer"><div class="c-footer__container"><div class="c-footer__link-group"><h5 class="u-fw-bold">Account</h5><ul class="b-bare"><li class="b-bare u-mar-vt-20"><a class="c-footer__link" href="https://account.covermymeds.com/">Login</a></li><li class="b-bare u-mar-vt-20"><a class="c-footer__link" href="../../../../signup.html">Sign up</a></li><li class="b-bare u-mar-vt-20"><a class="c-footer__link" href="../../../../request/key/index.html">Enter key</a></li><li class="b-bare u-mar-vt-20"><a class="c-footer__link" href="../../../../user/forgot.html">Trouble logging in?</a></li></ul></div><div class="c-footer__link-group"><h5 class="u-fw-bold">Solutions</h5><ul class="b-bare"><li class="b-bare u-mar-vt-20"><a class="c-footer__link" href="../../../solutions/patient-support-services/index.html">Patient Journey</a></li><li class="b-bare u-mar-vt-20"><a class="c-footer__link" href="../../../solutions/medication-access.1.html">Access</a></li><li class="b-bare u-mar-vt-20"><a class="c-footer__link" href="../../../solutions/provider/rxbc.html">Adherence</a></li><li class="b-bare u-mar-vt-20"><a class="c-footer__link" href="../../../solutions/medication-affordability.1.html">Affordability</a></li></ul></div><div class="c-footer__link-group"><h5 class="u-fw-bold">Resources</h5><ul class="b-bare"><li class="b-bare u-mar-vt-20"><a class="c-footer__link" href="../../index.html">Insights</a></li><li class="b-bare u-mar-vt-20"><a class="c-footer__link" href="../../../support/index.html">Support</a></li><li class="b-bare u-mar-vt-20"><a class="c-footer__link" href="https://insights.covermymeds.com/medication-access-report">Medication Access Report</a></li><li class="b-bare u-mar-vt-20"><a class="c-footer__link" href="https://www.covermymeds.com/main/insights/press/">Press</a></li><li class="b-bare u-mar-vt-20"><a class="c-footer__link" href="../../../support/contact/index.html">Contact</a></li><li class="b-bare u-mar-vt-20"><a class="c-footer__link" href="../../../support/developers/index.html">Developers</a></li></ul></div><div class="c-footer__link-group"><h5 class="u-fw-bold">Company</h5><ul class="b-bare"><li class="b-bare u-mar-vt-20"><a class="c-footer__link" href="../../../about/index.html">About</a></li><li class="b-bare u-mar-vt-20"><a class="c-footer__link" href="https://experience.covermymeds.com/">Careers</a></li><li class="b-bare u-mar-vt-20"><a class="c-footer__link" href="https://www.covermymeds.com/main/about/leadership/">Leadership</a></li><li class="b-bare u-mar-vt-20"><a class="c-footer__link" href="../../../about/events/index.html">Events</a></li><li class="b-bare u-mar-vt-20"><a class="c-footer__link" href="../../../about/privacy/index.html">Privacy</a></li><li class="b-bare u-mar-vt-20"><a class="c-footer__link" href="../../../about/privacy/responsible-disclosure-program/index.html">Responsible Disclosure Program</a></li><li class="b-bare u-mar-vt-20"><a class="c-footer__link" href="../../../partners/index.html">Our Partners</a></li></ul></div><div class="c-footer__subscribe gtm-subscribe "><h5 class="u-fw-bold">Subscribe to Insights</h5><p class="u-mar-vt-35">Get faster access to the industry news, research reports and expert opinions on key issues that matter to you.</p><form class="c-footer__form"><div class="c-footer__email"><div class="b-body c-textbox c-textbox--has-background"><label for="0SQrfavPO1spiEyLau7pO_5ENpdH3KytP2UFVaKLUvSm_field" class=" c-textbox__label">Email address</label><input class="b-bare c-textbox__field" type="email" id="0SQrfavPO1spiEyLau7pO_5ENpdH3KytP2UFVaKLUvSm_field" pattern="[a-zA-Z0-9._%+-]+@[a-zA-Z0-9.-]+.[a-zA-Z]{2,4}$" name="email" required="" value=""/></div></div><div class="c-footer__submit"><button class="c-btn u-width-100 undefined"><span class="c-btn__txt">Subscribe</span></button></div></form></div><div class="c-footer__rule"></div><div class="b-attribution c-footer__copyright">© 2024 CoverMyMeds LLC. All Rights Reserved.</div><ul class="b-bare c-footer__social"><li class="b-bare c-footer__social-item"><a class="b-bare c-footer__icon-link" href="https://facebook.com/CoverMyMeds/" target="_blank"><img src="https://images.ctfassets.net/2in405srp47m/5chqa8TMSHhloDolfZwD3G/ad063917c3e970ca28bb2e01e1928248/social_fb.svg" class="c-footer__icon" alt="CoverMyMeds on Facebook"/></a></li><li class="b-bare c-footer__social-item"><a class="b-bare c-footer__icon-link" href="https://twitter.com/CoverMyMeds" target="_blank"><img src="https://images.ctfassets.net/2in405srp47m/5qC5FTWs5i9hldrP3Gw4RY/0fd996be97bbfac68fbf9cf9d999f420/xSvg-01.svg" class="c-footer__icon" alt="CoverMyMeds on X"/></a></li><li class="b-bare c-footer__social-item"><a class="b-bare c-footer__icon-link" href="https://linkedin.com/company/covermymeds" target="_blank"><img src="https://images.ctfassets.net/2in405srp47m/5PHW2sNqZr1spoo5aOi0bV/8cc66b8041d7657a6b772a26270d9696/social_li.svg" class="c-footer__icon" alt="CoverMyMeds on LinkedIn"/></a></li><li class="b-bare c-footer__social-item"><a class="b-bare c-footer__icon-link" href="https://instagram.com/covermymeds/" target="_blank"><img src="https://images.ctfassets.net/2in405srp47m/34nDRFOtASbqGiZWLyT82y/dcd26f73d629f867556c658a85ef79a3/social_ig.svg" class="c-footer__icon" alt="CoverMyMeds on Instagram"/></a></li><li class="b-bare c-footer__social-item"><a class="b-bare c-footer__icon-link" href="https://glassdoor.com/Overview/Working-at-CoverMyMeds-EI_IE680605.11,22.htm" target="_blank"><img src="https://images.ctfassets.net/2in405srp47m/3EvIN78HWVdY7HQyNe9C6U/5215f264b4aa45ca14cdd67b53aab609/social_gd.svg" class="c-footer__icon" alt="CoverMyMeds on Glassdoor"/></a></li></ul></div></footer></div><script id="__NEXT_DATA__" type="application/json">{"props":{"pageProps":{"template":"Articles","analyticsData":{"insightsTitle":"A Change of Pace for Accessing Specialty Medications","insightsCategory":"Industry","insightsTopic":"Specialty Therapy","insightsPublishDate":"2019-10-10T00:00:00.000Z"},"metaProps":{"title":"A Change of Pace for Accessing Specialty Medications","socialDescription":"AMP: Access for More Patients, a new technology-driven solution from CoverMyMeds and RxCrossroads by McKesson, solves for many challenges accompanying specialty meds by leveraging network connections and creating efficiencies within provider workflows. ","socialImage":"https://images.ctfassets.net/70w6ftfzv4je/6TlTPN2Mv81tEzj5OmZSyc/153e4bbc6ed745e218bac708cb84be32/CMM_13803_preview.jpg","pageUrl":"https://insights.covermymeds.com/healthcare-industry/specialty-therapy/a-change-of-pace-for-accessing-specialty-medications"},"templateProps":{"article":{"sys":{"id":"42O1AA3IP6CvA7V0l51EGT","publishedAt":"2021-11-30T21:06:53.755Z","__typename":"Sys"},"includeSectionLinks":null,"title":"A Change of Pace for Accessing Specialty Medications","slug":"a-change-of-pace-for-accessing-specialty-medications","date":"2019-10-10T00:00:00.000Z","introduction":"Among ~5.8 billion prescriptions filled each year, about 2 percent (or 116 million) are written for specialty therapies.[ref](https://www.iqvia.com/institute/reports/medicine-use-and-spending-in-the-us-review-of-2017-outlook-to-2022 \"Medicine Use and Spending in the U.S., A Review of 2017 and Outlook to 2022, IQVIA Institute, 2018\") These medications can be highly complex and significantly more expensive than traditional pharmaceuticals — presenting patients with some of the most difficult prescription access challenges in healthcare. ","editorsNote":null,"category":{"title":"Industry","slug":"healthcare-industry","__typename":"Categories"},"topic":{"title":"Specialty Therapy","slug":"specialty-therapy","__typename":"Topics"},"featureImage":{"image":{"url":"https://images.ctfassets.net/70w6ftfzv4je/6TlTPN2Mv81tEzj5OmZSyc/153e4bbc6ed745e218bac708cb84be32/CMM_13803_preview.jpg","__typename":"Asset"},"altText":"A concerned female patient listening to a provider","caption":null,"photographer":null,"__typename":"ImageBlock"},"author":{"fullName":"Erica Conroy, PhD","jobTitle":"VP, Specialty               ","shortBio":"Erica delivered specialty solutions for patients, providers, pharmacists, payers and life sciences.","slug":"erica-conroy-phd","hasPage":false,"photo":{"url":"https://images.ctfassets.net/70w6ftfzv4je/6pLPtmI9DH1ZyvqCm3KilS/c6eb630b61f9c4344deebd89f6f9eb08/CMM_Leadership_12-6-75.jpg","__typename":"Asset"},"__typename":"Authors"},"bodyCollection":{"items":[{"__typename":"MarkdownBlock","sys":{"id":"5tGMcl14HY28bxr0HiRtB8","__typename":"Sys"},"content":"Compared to conventional medications, patients and providers must complete additional clinical and administrative requirements before specialty medications can be dispensed or reimbursed. Complicated workflows, along with back and forth transactions among healthcare stakeholders, can leave patients struggling to get the therapies they need. [AMP: Access for More Patients\u0026trade;](https://www.covermymeds.com/main/solutions/life-sciences/specialty/ \"AMP: Access for More Patients\"), a new technology-driven solution from CoverMyMeds and RxCrossroads by McKesson, solves for many challenges accompanying specialty medications by leveraging network connections and creating efficiencies within provider workflows.\n\nAMP changes the way providers and patients experience support services for specialty medications. At each stage of the specialty workflow, AMP creates efficiencies and applies network solutions to overcome long-standing challenges.\n\n# Support Challenges\n\nSupport programs serve as an important resource for patients beginning a specialty therapy by providing services to help with medication access, affordability and adherence. Enrolled patients are connected with financial assistance programs, receive education on their therapies and obtain the help needed to coordinate care.[ref](https://www.accenture.com/_acnmedia/accenture/next-gen/patient-services-survey/accenture-mc814-patient-servicesls-research-note2015-v7.pdf \"Patient Services – Pharma’s Best Kept Secret, Accenture Life Sciences, 2016\") While support services lend a much needed helping hand, a survey to 10,000 patients across several therapeutic areas found that only one in five were aware of such programs.[ref](https://www.accenture.com/_acnmedia/accenture/next-gen/patient-services-survey/accenture-mc814-patient-servicesls-research-note2015-v7.pdf \"Patient Services – Pharma’s Best Kept Secret, Accenture Life Sciences, 2016\") For many patients, this means their only chance of connecting with a support program is through their provider. \n\nTo enroll patients in support services, providers must be aware that a program exists for a given specialty medication and locate the correct enrollment form. After completing the form, providers have traditionally faxed it to the appropriate organization for processing (*i.e.*, pharmaceutical manufacturer, specialty pharmacy or hub provider).[ref](https://www.pocp.com/hit-perspecitves-automating-enrollment-specialty-prescriptions/ \"HIT Perspectives: Automating Enrollment for Specialty Prescriptions, Point of Partners, 2017\") Alternatively, enrollment via web portals is sometimes available, but it’s up to providers to remember individual login credentials for each program, which can be difficult information to keep track of.[ref](https://www.pmlive.com/pharma_intelligence/simplifying_hcp_access_to_digital_information_1216451 \"Simplifying HCP Access to Digital Information, PMLiVE, 2018\") It’s estimated that less than 10 percent of patient enrollment for specialty support services is completed electronically.[ref](https://pocp.com/wp-content/uploads/PDF/6-%20NCPDP_2015_ED_Summit_SpecialtyRx.pdf \"Automating Specialty Pharmacy: Identifying Gaps, NCPDP, 2015\")\n\n# Specialty Prescribing and Enrollment\n\nAMP is revolutionizing patient access to support services for specialty medications by linking together two major steps in the specialty workflow: prescribing and enrollment. Technology innovation and key network connections allow AMP to funnel enrollment through the point of prescribing to give all patients the opportunity to experience support services. Through AMP, specialty medications can be e-prescribed to a non-dispensing pharmacy, such as ScriptHero Pharmacy, which can serve as the central location for all specialty prescriptions. Behind the scenes, AMP fulfills all the complex requirements [*e.g.*, benefits investigation (BI), benefits verification (BV), prior authorization (PA), lab scheduling, prescription titration, etc.] for starting patients on therapy, while the non-dispensing pharmacy triages prescriptions to the appropriate specialty pharmacy in a given limited distribution network for dispense to patients. \n\nIndustry-wide, the standard for specialty prescribing and enrollment has involved paper, phone and fax-based processes. Not only are phone calls and faxes outdated methods of communication – contributing to office inefficiencies for providers and their staff – there is little direction for where specialty prescriptions must be sent. As a result, more than 40 percent of faxed specialty prescriptions require call back to the provider.[ref](https://pocp.com/wp-content/uploads/PDF/6-%20NCPDP_2015_ED_Summit_SpecialtyRx.pdf \"Automating Specialty Pharmacy: Identifying Gaps, NCPDP, 2015\") In addition, more than 85 percent of surveyed providers reported a lack of digital access to specialty pharmacy information within their EHR systems for where to send prescriptions.[ref](https://www.pocp.com/wp-content/uploads/NCPDP-AC2019-Specialty-Prescribers-Tell-All-w-ACPE-slides_FINAL_SM.pdf \"Specialty Prescribers Tell All, NCPDP Conference Presentation, 2019\") AMP overcomes this challenge as providers only need to prescribe to a central, non-dispensing pharmacy, like ScriptHero Pharmacy, for specialty prescriptions to be processed and sent to the right location for dispense. \n\nTo meet providers where they are, AMP allows for enrollment into support services to be completed in multiple other ways as well. As soon as an e-prescription for a specialty medication is written, enrollment can be automatically triggered within the familiar CoverMyMeds web portal, which is already used by over 700,000 providers for submitting PA requests electronically.[ref](https://www.drugchannels.net/2019/05/a-new-starting-point-for-patient.html \"A New Starting Point for Patient Support: Technology-Driven Hub Services, Drug Channels, 2019\") In fact, data from [a recent two-month pilot study](https://www.covermymeds.com/main/insights/articles/amp-access-for-more-patients-tm-improves-time-to-therapy-for-specialty/ \"End-To-End Electronic Support Improves Patient Access for Specialty Medications\") of a neurology medication for a narrow patient population demonstrates AMP’s advantage for reaching providers. During the pilot, 89 percent of prospective providers (*i.e.*, 501 out of 562 national provider identifiers) enrolled patients into AMP, and 48 percent of enrollments were completed electronically, as compared to the industry standard of less than 10 percent.[ref](https://www.covermymeds.com/main/insights/articles/amp-access-for-more-patients-tm-improves-time-to-therapy-for-specialty/ \"Access for More Patients Delivers End-to-End Electronic Support for Specialty Medications, CoverMyMeds, 2019\") Data also showed that when enrollment forms were started, 92 percent were completed relative to the industry standard completion rate of 50 percent.[ref](https://www.covermymeds.com/main/insights/articles/amp-access-for-more-patients-tm-improves-time-to-therapy-for-specialty/ \"Access for More Patients Delivers End-to-End Electronic Support for Specialty Medications, CoverMyMeds, 2019\")\n\nAs an added benefit, patient information from an e-prescription is auto-populated directly into the enrollment form, helping providers to save time. If the medication is not e-prescribed, providers can also choose to manually start enrollment within the CoverMyMeds portal or use more traditional methods, like fax, to complete enrollment. \n\n# Coordinating Care\n\nFor many patients, the reimbursement component of starting specialty therapy is most challenging. Knowing who to contact for answers and assistance can be difficult even for healthcare experts, let alone struggling patients. In fact, some patients have described working through these activities on their own as a full-time job.[ref](https://www.covermymeds.com/main/insights/articles/amp-access-for-more-patients-tm-improves-time-to-therapy-for-specialty/ \"Access for More Patients Delivers End-to-End Electronic Support for Specialty Medications, CoverMyMeds, 2019\") Reimbursement involves processes like BI, BV and PA which require information transfer among patients, providers, pharmacies and payers. When multiple healthcare stakeholders are needed to coordinate reimbursement activities, it typically takes more time to facilitate patient care. \n\nAMP is changing the way care is coordinated with an online self-service dashboard that facilitates workflow organization and efficiency. Stakeholders are alerted to outstanding steps along with who is responsible for completion. Through such network connectivity, AMP can increase workflow visibility and transparency among members of the patient care team while allowing for real-time transfer of pertinent information to help prevent delays in time-to-therapy. \n\nComplicated insurance-related requirements are available for electronic fulfillment through AMP and fit within a standardized workflow to help improve efficiency and decrease time-to-therapy. In the past, these steps required weeks to fulfill – delaying time-to-therapy by eight weeks in some cases. In the [recent AMP pilot study](https://www.covermymeds.com/main/insights/articles/amp-access-for-more-patients-tm-improves-time-to-therapy-for-specialty/ \"End-To-End Electronic Support Improves Patient Access for Specialty Medications\"), all three of these major reimbursement activities were completed in a total of 11 days on average.[ref](https://www.covermymeds.com/main/insights/articles/amp-access-for-more-patients-tm-improves-time-to-therapy-for-specialty/ \"Access for More Patients Delivers End-to-End Electronic Support for Specialty Medications, CoverMyMeds, 2019\")\n\n# Exception Management and Outcomes\n\nAs specialty medications exist on a spectrum of complexity, every patient case may not be amendable to the standard workflow. These exceptions are managed by a highly skilled team of case managers that work quickly to resolve outstanding issues. After therapy begins, AMP case managers continue supporting positive outcomes through regular check-ins and communication with patients to help them remain on therapy. \n\nSpecialty medications are bringing hope to many patients suffering from difficult-to-treat conditions and rare diseases, but access barriers can stand in the way of wellness. AMP addresses the challenges confronting patients at each stage of their journeys, from access to adherence. \n\n__*To learn more about how AMP is providing patients with the end-to-end support needed for specialty therapies, visit [go.covermymeds.com/specialty](https://www.covermymeds.com/main/solutions/life-sciences/specialty/ \"AMP: Access for More Patients\").*__","isKeyTakeaway":false}],"__typename":"ArticlesBodyCollection"},"gate":null,"__typename":"Articles"},"relatedArticles":[{"articleTitle":"Asembia 2023: Payers, Pharma and Pharmacy Discuss Patient Access","articleUrl":"https://insights.covermymeds.com/healthcare-industry/specialty-therapy/asembia-2023-payers-pharma-and-pharmacy-discuss-patient-access","topicTitle":"Specialty Therapy","topicUrl":"/topics/specialty-therapy","authorName":"Editorial Team ","authorUrl":null,"imageUrl":"https://images.ctfassets.net/70w6ftfzv4je/6GM3sRxEi9JsFyn7D5XbaU/bb5bc1475f4aec0e400fc5b99a9a74cd/CMM_461226_Content_Assembia_Pre_Show_Digital_v01a_Email_Header_WED_1200x600_copy_3.png","imageAlt":"Asembia 2023: Payers, Pharma and Pharmacy Discuss Patient Access","openInNewTab":false},{"articleTitle":"Asembia 2023: Expectations and Policy Impacts for Specialty Therapies","articleUrl":"https://insights.covermymeds.com/healthcare-industry/specialty-therapy/asembia-2023-expectations-and-policy-impacts-for-specialty-therapies","topicTitle":"Specialty Therapy","topicUrl":"/topics/specialty-therapy","authorName":"Editorial Team ","authorUrl":null,"imageUrl":"https://images.ctfassets.net/70w6ftfzv4je/sS7zsfkrx5lnLNNhCzIdK/f0fcb51cf003ccdc53b8ee096eee542c/CMM_461226_Content_Assembia_Pre_Show_Digital_v01a_Email_Header_MON_1200x600_copy.png","imageAlt":"Asembia 2023: Expectations and Policy Impacts for Specialty Therapies","openInNewTab":false},{"articleTitle":"Asembia 2023: An Active and Complex Future for Specialty Therapies","articleUrl":"https://insights.covermymeds.com/healthcare-industry/specialty-therapy/asembia-2023-an-active-and-complex-future-for-specialty-therapies","topicTitle":"Specialty Therapy","topicUrl":"/topics/specialty-therapy","authorName":"Editorial Team ","authorUrl":null,"imageUrl":"https://images.ctfassets.net/70w6ftfzv4je/6gFLRtVmLi70w1KbolgCWo/152628a67a3649e39b2a6d7815fa4cc8/CMM_461226_Content_Assembia_Pre_Show_Digital_v01a_Email_Header_TUE_1200x600_copy_2.png","imageAlt":"Asembia 2023: An Active and Complex Future for Specialty Therapies","openInNewTab":false}],"footnoteList":[{"title":"Medicine Use and Spending in the U.S., A Review of 2017 and Outlook to 2022, IQVIA Institute, 2018","href":"https://www.iqvia.com/institute/reports/medicine-use-and-spending-in-the-us-review-of-2017-outlook-to-2022"},{"title":"Patient Services – Pharma’s Best Kept Secret, Accenture Life Sciences, 2016","href":"https://www.accenture.com/_acnmedia/accenture/next-gen/patient-services-survey/accenture-mc814-patient-servicesls-research-note2015-v7.pdf"},{"title":"HIT Perspectives: Automating Enrollment for Specialty Prescriptions, Point of Partners, 2017","href":"https://www.pocp.com/hit-perspecitves-automating-enrollment-specialty-prescriptions/"},{"title":"Simplifying HCP Access to Digital Information, PMLiVE, 2018","href":"https://www.pmlive.com/pharma_intelligence/simplifying_hcp_access_to_digital_information_1216451"},{"title":"Automating Specialty Pharmacy: Identifying Gaps, NCPDP, 2015","href":"https://pocp.com/wp-content/uploads/PDF/6-%20NCPDP_2015_ED_Summit_SpecialtyRx.pdf"},{"title":"Specialty Prescribers Tell All, NCPDP Conference Presentation, 2019","href":"https://www.pocp.com/wp-content/uploads/NCPDP-AC2019-Specialty-Prescribers-Tell-All-w-ACPE-slides_FINAL_SM.pdf"},{"title":"A New Starting Point for Patient Support: Technology-Driven Hub Services, Drug Channels, 2019","href":"https://www.drugchannels.net/2019/05/a-new-starting-point-for-patient.html"},{"title":"Access for More Patients Delivers End-to-End Electronic Support for Specialty Medications, CoverMyMeds, 2019","href":"https://www.covermymeds.com/main/insights/articles/amp-access-for-more-patients-tm-improves-time-to-therapy-for-specialty/"}]},"hideNav":false,"hideFooter":false},"__N_SSG":true},"page":"/[category]/[topic]/[slug]","query":{"category":"healthcare-industry","topic":"specialty-therapy","slug":"a-change-of-pace-for-accessing-specialty-medications"},"buildId":"7yVo0_otchyu3Fx5tbzU0","isFallback":false,"isExperimentalCompile":false,"gsp":true,"scriptLoader":[]}</script></body></html>